Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Anv Sec Group Inc. (ANVS) Message Board

Addressing Vision Problems Could Lower Risk of Dem

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 124
(Total Views: 113)
Posted On: 09/27/2024 5:41:18 PM
Avatar
Posted By: NetworkNewsWire
Addressing Vision Problems Could Lower Risk of Dementia, Study Finds

New research suggests that addressing any issues with your vision may reduce your risk of future brain issues. The research was led by Jason Smith, an epidemiologist at the Bloomberg School of Public Health at Johns Hopkins.

For their research, the investigators analyzed data from more than 2,700 patients in the United States. They discovered that roughly 19% of cases of dementia could be linked to a vision issue. This included loss in near visual acuity and loss of sensitivity in detecting contrast. They also found that the link between dementia and vision was almost nine times higher when contrast sensitivity was included as a variable.

In addition, they found that improvements to common vision issues could possibly prevent at least one in five cases of dementia in older individuals.

In their report, the researchers hypothesized that visual impairment affected the risk of dementia via similar mechanisms, such as hearing loss. Here, they were referring to proteins linked to neurodegeneration affecting nerves that play a role in auditory sensing. Alternatively, they theorized that decreased sensory perceptions prompted the brain to try compensating for the loss, which resulted in other areas receiving fewer resources.

They also highlighted that addressing risk factors was a priority for strategies to prevent dementia, especially since the disease’s prevalence is increasing in the United States as well as globally.

The researchers didn’t include the impact of using contact lenses or glasses. They also didn’t include some minority groups, which means the results cannot be generalized across all populations. It should be noted that the research doesn’t prove that visual issues cause dementia, only that the conditions are linked. This may mean that factors that hadn’t been previously considered may be involved in both conditions.

Prior studies do, however, suggest the presence of a link between the two.

One post-mortem investigation involving donors who had been diagnosed with cognitive issues found that changes in their retinas corresponded to changes in brain regions responsible for perception of time and memory. Additionally, certain eye conditions seem to be correlated with some types of dementia. For example, glaucoma tends to happen alongside vascular degeneration while age-related macular degeneration appears to be tied to Alzheimer’s disease.

In a 2018 study, Dr. Heather Whitson and colleagues at Duke University found that sensory loss could lead to decreased physical activity, depression and social isolation, which could cause impairment in an individual’s cognitive function. This means that there’s a possibility that addressing issues with one’s vision could alleviate factors that lead to dementia.

About 80% of visual impairments can be prevented or treated, with visual rehabilitation helping where vision loss isn’t reversible.

The researchers reported their findings in “JAMA Ophthalmology.”

Various research teams at companies such as Annovis Bio Inc. (NYSE: ANVS) are focused on understanding why and how neurodegenerative conditions, including Alzheimer’s disease, develop. As more information on their development becomes available, it will be easier to bring to market treatments that actually move the dial on the progression of these conditions.

NOTE TO INVESTORS: The latest news and updates relating to Annovis Bio Inc. (NYSE: ANVS) are available in the company’s newsroom at https://ibn.fm/ANVS

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer



(0)
(0)




Anv Sec Group Inc. (ANVS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us